It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Adolescent girls and young women represent a key risk group for sexually transmitted infections (STIs). The vaginal microbiota is thought to play an important role in susceptibility to STIs such as Chlamydia trachomatis. We compared the microbiota of the lateral vaginal wall and endocervix, and assessed associations with C. trachomatis infection in South African adolescents. The endocervical and vaginal lateral wall microbiota were characterized by amplifying and sequencing the V4 region of the 16S rRNA gene and C. trachomatis diagnosed using molecular methods. Of the 72 girls included, 30 had asymptomatic C. trachomatis infections. Three major vaginal community types were identified; one Lactobacillus crispatus, one L. iners and one diverse, Gardnerella vaginalis dominant. The microbiota of the endocervix was significantly different from that of the lateral wall in terms of diversity. There were many differentially abundant taxa between the endocervix and lateral vaginal wall, including Achromobacter spanius and Enterococcus faecium. Women with C. trachomatis had higher relative abundance of G. vaginalis and other anaerobes. In this African adolescent cohort, significant differences between the lateral vaginal wall and endocervical microbiota diversity and composition were evident, although neither were strongly associated with C. trachomatis infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Institute of Infectious Disease and Molecular Medicine & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa
2 Institute of Infectious Disease and Molecular Medicine & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Computational Biology Division, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa
3 Institute of Institute of Infectious Disease and Molecular Medicine & Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa
4 Institute of Institute of Infectious Disease and Molecular Medicine & Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
5 Seattle Children’s Research Institute, Seattle, WA, USA
6 National Institute for Communicable Diseases, Sandringham, Johannesburg, South Africa
7 Institute of Institute of Infectious Disease and Molecular Medicine & Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Center for HIV and STIs, National Institute for Communicable Disease, National Health Laboratory Service, Johannesburg, South Africa; SAMRC-UCT Clinical Gynaecological Cancer Research Centre, University of Cape Town, Cape Town, South Africa
8 Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
9 National Institute for Communicable Diseases, Sandringham, Johannesburg, South Africa; Western Sydney Sexual Health Centre, Parramatta, Australia; Marie Bashir Institute for Infectious Diseases and Biosecurity & Sydney Medical School-Westmead, University of Sydney, Sydney, Australia
10 Institute of Institute of Infectious Disease and Molecular Medicine & Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa; DST-NRF CAPRISA Centre of Excellence in HIV Prevention, Durban, South Africa; National Health Laboratory Service Cape Town, Cape Town, South Africa
11 Institute of Infectious Disease and Molecular Medicine & Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Seattle Children’s Research Institute, Seattle, WA, USA; University of Washington Department of Pediatrics and Global Health, Seattle, WA, USA